文献速递其他结缔组织病系统性红斑狼疮

JAK抑制剂在炎性关节炎以外领域的应用:聚焦结缔组织病

JAK inhibitors in areas outside of inflammatory arthritis: focus on connective tissue diseases.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该综述指出JAK抑制剂通过靶向多种细胞因子网络在自身免疫病中具变革性治疗作用,在特发性炎性肌病、系统性硬化症、原发性干燥病和系统性红斑狼疮等结缔组织病中显示潜在疗效。早期临床试验和真实世界数据证实难治性疾病中有意义应答,但随机证据仍有限。

要点

  • JAK抑制剂在特发性炎性肌病、系统性硬化症等结缔组织病中显示潜在疗效。
  • 通过调节I/II型干扰素和白细胞介素信号发挥抗炎和抗纤维化作用。
  • 早期试验和真实世界数据证实难治性疾病应答,随机证据有限。

核心结论

  • JAK抑制剂是机制合理且有前景的系统性自身免疫病治疗选择,正在进行的研�究有望优化选择性、适应证和长期安全性。

研究设计与样本

  • 综述,聚焦JAK抑制剂在炎性关节炎以外领域尤其是结缔组织病中的应用。

主要发现

  • JAK抑制剂通过调节I/II型干扰素和白细胞介素信号,产生广泛抗炎和抗纤维化效应,转化为皮肤、关节和肺部领域的临床改善。
  • 早期临床试验和真实世界数据证实难治性疾病中有意义应答,但随机证据仍有限。

临床怎么用

  • JAK抑制剂可作为难治性结缔组织病(如特发性炎性肌病、系统性硬化症、原发性干燥病、系统性红斑狼疮)的有前景选择,但需注意随机证据有限。

局限性

  • 随机证据仍有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Janus kinase (JAK) inhibitors have emerged as a transformative therapeutic class across autoimmune diseases by targeting multiple cytokine networks implicated in inflammation and fibrosis. Beyond inflammatory arthritis, increasing evidence supports their potential efficacy in connective tissue diseases such as idiopathic inflammatory myopathies, systemic sclerosis, primary Sjögren's disease, and systemic lupus erythematosus. Through modulation of type I/II interferon and interleukin signalling, JAK inhibition exerts broad anti-inflammatory and antifibrotic effects, translating into clinical improvements in cutaneous, articular and pulmonary domains. Early clinical trials and real-world data confirm meaningful responses in refractory disease, though randomized evidence remains limited. Overall, JAK inhibitors represent a promising, mechanistically grounded option for systemic autoimmune diseases, with ongoing studies expected to refine selectivity, indications and long-term safety profiles.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bruno L, Cafaro G, Dal Pozzolo R, et al. JAK inhibitors in areas outside of inflammatory arthritis: focus on connective tissue diseases. Rheumatology (Oxford). 2026. PMID: 42320040. doi:10.1093/rheumatology/keag317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。